We offer several clinical trials for multiple types of cancer and participate in as many as 50 to 100 clinical trials with partnering cancer centers. These clinical trials give our patients access to emerging treatment options right here in Spokane, eliminating the need to travel outside of the Inland Northwest for the latest in cancer treatment. The clinical trials also provide important information to help conquer cancer.
Before beginning treatment, you may want to consider participating in a clinical trial. Talk with your medical oncologist, surgical oncologist or radiation oncologist to determine if this is a good option for you.
What is a clinical trial?
Clinical trials are research studies that help determine the effectiveness of a new drug or treatment. Each clinical trial is designed to answer specific scientific questions and to help find potentially better ways to prevent, diagnose or treat cancer.
Why are clinical trials important?
Clinical trials are a vital part of the process in finding new cancer treatments and ultimately a cure for cancer. Without these research studies, many of the advances we see today in cancer detection, treatment and prevention would never have happened.
For More Information
If you are interested in a clinical trial and would like more information to discuss with our Cancer Care Northwest physician, please email the Cancer Care Northwest Research Department at email@example.com for more information. Be sure to include:
Using the dropdown menu below, you can search and request more information for open trials.
A Phase 2, Randomized, Parallel, Open-Label Study to Investigate the Safety, Efficacy, and Pharmacokinetics of Various Dosing Regimens of Single-Agent Belantamab Mafodotin (GSK2857916) in Participants with Relapsed or Refractory Multiple Myeloma (DREAMM-14).View Details
A Phase 3 Study to Evaluate the Efficacy and Safety of Enobosarm in Combination with Abemaciclib (Enobosarm Combination Group) compared to Estrogen Blocking Agent (Control Treatment Group) for the Second Line Treatment of ER+HER2- Metastatic Breast Cancer in Patients Who Have Shown Previous Disease Progression on an Estrogen Blocking Agent plus Palbociclib.View Details
This study will collect de-identified tumor samples, with correlated clinical/demographic data and tissue histology, from patients selected or scheduled for pre-treatment tumor biopsy or who have had a recent pre-treatment tumor biopsy. These specimens and clinical data may be used in subsequent studies for the development and validation of a diagnostic test.View Details
A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Enobosarm Monotherapy Versus Active Control for the Treatment of AR+/ER+/HER2- Metastatic Breast Cancer in Patients with Androgen Receptor Nuclei Staining ≥40% Who Have Shown Previous Disease Progression on a Nonsteroidal Aromatase Inhibitor, Fulvestrant and CDK 4/6 inhibitor.View Details
GRECO-2: A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4711 in the Treatment of Unresectable or Borderline Resectable, Nonmetastatic Pancreatic CancerView Details
A Phase 3 Randomized, Open-Label, Multicenter Study Comparing Zanubrutinib (BGB-3111) plus Rituximab Versus Bendamustine plus Rituximab in Patients with Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation.View Details